ALDH1A Isozymes are Markers of Human Melanoma Stem Cells and Potential Therapeutic Targets

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Stem Cells

• Publication date

  2012-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/stem.1193PMID 22887839PMCID PMC3448863
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Side Population Cells from Human Melanoma Tumors Reveal Diverse Mechanisms for Chemoresistance

  2012cited by this paper
• Pitavastatin-induced angiogenesis and arteriogenesis is mediated by Notch1 in a murine hindlimb ischemia model without induction of VEGF

  2011cited by this paper
• The role of stem and circulating cells in cancer metastasis

  2011cited by this paper
• Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.

  2011cited by this paper
• Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells Is Primarily Due To Isoform ALDH1A3 and Its Expression Is Predictive of Metastasis

  2011cited by this paper
• VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth.

  2011cited by this paper
• Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth.

  2011cited by this paper
• Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99‐1 cells based on high aldehyde dehydrogenase activity

  2011cited by this paper
• Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271

  2011cited by this paper
• High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer.

  2010cited by this paper
• Aldehyde Dehydrogenase (ALDH) Activity Does Not Select for Cells with Enhanced Aggressive Properties in Malignant Melanoma

  2010cited by this paper
• Human Melanoma Initiating Cells Express Neural Crest Nerve Growth Factor Receptor CD271

  2010cited by this paper
• Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized.

  2010cited by this paper
• Selection of tumorigenic melanoma cells using ALDH.

  2010cited by this paper
• Single‐marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase

  2010cited by this paper
• Tumor-initiating cells are rare in many human tumors.

  2010cited by this paper
• Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma.

  2010cited by this paper
• Tumorigenic and metastatic activity of human thyroid cancer stem cells.

  2010cited by this paper
• Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems.

  2009cited by this paper
• Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature.

  2009cited by this paper
• High Aldehyde Dehydrogenase Activity: A Novel Functional Marker of Murine Prostate Stem/Progenitor Cells

  2009cited by this paper
• High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability

  2009cited by this paper
• Aldehyde dehydrogenase activity as a functional marker for lung cancer.

  2009cited by this paper
• Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer

  2009cited by this paper
• Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer

  2009cited by this paper
• Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer.

  2009cited by this paper
• Non-P 450 aldehyde oxidizing enzymes : the aldehyde dehydrogenase superfamily

  2009cited by this paper
• Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer.

  2009cited by this paper
• Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.

  2009cited by this paper
• Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma.

  2009cited by this paper
• Efficient tumor formation by single human melanoma cells

  2008cited by this paper
• Identification of cells initiating human melanomas

  2008cited by this paper
• Medium- and short-chain dehydrogenase/reductase gene and protein families

  2008cited by this paper
• Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily

  2008cited by this paper
• Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy

  2008cited by this paper
• Efficient tumour formation by single human melanoma cells

  2008cited by this paper
• Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis.

  2008cited by this paper
• Medium- and short-chain dehydrogenase/reductase gene and protein families

  2008cited by this paper
• ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

  2007cited by this paper
• Cancer Stem Cells

  2007cited by this paper
• Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential.

  2007cited by this paper
• Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells.

  2006cited by this paper
• An In vivo Platform for Translational Drug Development in Pancreatic Cancer

  2006cited by this paper
• Cancer stem cells.

  2006cited by this paper
• Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

  2006cited by this paper
• Identification of a Primitive Brain–Derived Neural Stem Cell Population Based on Aldehyde Dehydrogenase Activity

  2006cited by this paper
• Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells.

  2006cited by this paper
• A tumorigenic subpopulation with stem cell properties in melanomas.

  2005cited by this paper
• A robust characterization of retinoic acid response elements based on a comparison of sites in three species.

  2005cited by this paper
• Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family

  2005cited by this paper
• Phenotypic Characterization of Murine Primitive Hematopoietic Progenitor Cells Isolated on Basis of Aldehyde Dehydrogenase Activity

  2004cited by this paper
• Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity.

  2004cited by this paper
• Phase II evaluation of paclitaxel by short intravenous infusion in metastatic melanoma

  2004cited by this paper
• Phase II study of pegylated liposomal doxorubicin in patients with metastatic malignant melanoma failing standard chemotherapy treatment

  2003cited by this paper
• Aldehyde dehydrogenase gene superfamily: the 2002 update.

  2003cited by this paper
• Stem cells, cancer, and cancer stem cells

  2001cited by this paper
• Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer.

  1996cited by this paper
• Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma.

  1995cited by this paper
• Multiplicity generates diversity in the retinoic acid signalling pathways.

  1992cited by this paper

• Neural crest gene regulatory networks as drivers of development, diversification and disease.

  2026cites this paper
• Investigating the therapeutic effect of metformin on melanoma cancer stem cells using optical microscopy.

  2026cites this paper
• Clinical significance and expression of ALDH1 in triple-negative breast cancer

  2025cites this paper
• Advances in Nanomedicine for Targeting Cancer Stem Cells and Overcoming Therapeutic Resistance.

  2025cites this paper
• Insights into the Multifaceted Roles and Pleiotropic Functions of ALDH1L2 with Implications in Gastrointestinal Diseases and Cancer

  2025cites this paper
• Cancer Stem Cells in Melanoma: Drivers of Tumor Plasticity and Emerging Therapeutic Strategies

  2025cites this paper
• ALDH1A inhibitors: Research advances in cancer therapeutics.

  2025cites this paper
• Confronting Melanoma Radioresistance: Mechanisms and Therapeutic Strategies

  2025cites this paper
• Novel Uveal Melanocyte Cell Lines Display Distinct Features from Uveal Melanoma

  2025cites this paper
• Electrochemical and MEMS-based biosensors for quantifying ALDH1A1 expression and activity in non-small cell lung cancer cell lines

  2025cites this paper
• Uncovering minimal pathways in melanoma initiation

  2025cites this paper
• PRMT6 Inhibits Malignant Progression of Melanoma by Antagonizing Trimethylation of Histone H3K4 to Downregulate ALDH1A1 Levels

  2025cites this paper
• Double-sided niche regulation in skin stem cell and cancer: mechanisms and clinical applications

  2025cites this paper
• Cancer drug-tolerant persister cells: from biological questions to clinical opportunities

  2024cites this paper
• ALDH1A3 contributes to tumorigenesis in high-grade serous ovarian cancer by epigenetic modification.

  2024cites this paper
• The roles of cancer stem cells and therapeutic implications in melanoma

  2024cites this paper
• ALDH1A3 is the switch that determines the balance of ALDH+ and CD24−CD44+ cancer stem cells, EMT-MET, and glucose metabolism in breast cancer

  2024cites this paper
• ALDH1A3-acetaldehyde metabolism potentiates transcriptional heterogeneity in melanoma

  2024cites this paper
• Aldehyde Dehydrogenase-1A1 (ALDH1A1): The Novel Regulator of Chemoresistance in Pancreatic Cancer Cells

  2024cites this paper
• Progress in antitumor mechanisms and applications of phenformin (Review)

  2024cites this paper
• ALDH and cancer stem cells: Pathways, challenges, and future directions in targeted therapy.

  2024cites this paper
• The critical role of glutamine and fatty acids in the metabolic reprogramming of anoikis-resistant melanoma cells

  2024cites this paper
• The Significance of Aldehyde Dehydrogenase 1 in Cancers

  2024cites this paper
• Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways

  2024cites this paper
• Development of substituted benzimidazoles as inhibitors of human aldehyde dehydrogenase 1A isoenzymes.

  2024cites this paper
• The pathogenic role of retinoid nuclear receptor signaling in cancer and metabolic syndromes

  2024cites this paper
• Aldehyde dehydrogenase in solid tumors and other diseases: Potential biomarkers and therapeutic targets

  2023cites this paper
• Lack of Cyclin E1 in hepatocytes aggravates ethanol-induced liver injury and hepatic steatosis in experimental murine model of acute and chronic alcohol-associated liver disease.

  2023cites this paper
• Modification of lysine-260 2-hydroxyisobutyrylation destabilizes ALDH1A1 expression to regulate bladder cancer progression

  2023cites this paper
• The Concept of Cancer Stem Cells: Elaborating on ALDH1B1 as an Emerging Marker of Cancer Progression

  2023cites this paper
• In Vitro Evaluation of ALDH1A3-Affinic Compounds on Breast and Prostate Cancer Cell Lines as Single Treatments and in Combination with Doxorubicin

  2023cites this paper
• ALDEFLUOR activity, ALDH isoforms, and their clinical significance in cancers

  2023cites this paper
• Novel Function of Cancer Stem Cell Marker ALDH1A3 in Glioblastoma: Pro-Angiogenesis through Paracrine PAI-1 and IL-8

  2023cites this paper
• Putative Cancer Stem Cell Markers are Frequently Expressed by Melanoma Cells in Vitro and in Situ but are also Present in Benign Differentiated Cells.

  2023cites this paper
• ALDH1A3 promotes invasion and metastasis in triple‐negative breast cancer by regulating the plasminogen activation pathway

  2023cites this paper
• The Impact of Low Protein Diet on the Molecular and Cellular Development of the Fetal Kidney

  2023cites this paper
• Human Aldehyde Dehydrogenases: A Superfamily of Similar Yet Different Proteins Highly Related to Cancer

  2023cites this paper
• The Expanding Role of Cancer Stem Cell Marker ALDH1A3 in Cancer and Beyond

  2023influential citation
• Oxidative Stress in Melanoma: Beneficial Antioxidant and Pro-Oxidant Therapeutic Strategies

  2023cites this paper
• Exploring Prognostic Biomarkers of Acute Myeloid Leukemia to Determine Its Most Effective Drugs from the FDA-Approved List through Molecular Docking and Dynamic Simulation

  2023cites this paper
• Cancer stem cells: an insight into the development of metastatic tumors and therapy resistance

  2023cites this paper
• Emerging role of interactions between tumor angiogenesis and cancer stem cells.

  2023cites this paper
• Ethanol Metabolism and Melanoma

  2023cites this paper
• Targeting aldehyde dehydrogenase enzymes in combination with chemotherapy and immunotherapy: An approach to tackle resistance in cancer cells.

  2023cites this paper
• Cross talk between tumor stemness and microenvironment for prognosis and immunotherapy of uveal melanoma

  2023cites this paper
• Targeting colorectal cancer with small-molecule inhibitors of ALDH1B1

  2022cites this paper
• Natural compounds as a potential modifier of stem cells renewal: Comparative analysis.

  2022cites this paper
• Expression of ALDH1 plays the important role during generation and progression in human cervical cancer

  2022cites this paper
• Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting

  2022cites this paper
• Drug-tolerant persister cells in cancer therapy resistance.

  2022cites this paper
• Lyophilized Gelatin@non-Woven Scaffold to Promote Spheroids Formation and Enrich Cancer Stem Cell Incidence

  2022cites this paper
• Metabolite profiling reveals a connection between aldehyde dehydrogenase 1A3 and GABA metabolism in breast cancer metastasis

  2022cites this paper
• Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells

  2022cites this paper
• Efficacy of an ALDH peptide-based dendritic cell vaccine targeting cancer stem cells

  2022cites this paper
• ALDH1A1 overexpression in melanoma cells promotes tumor angiogenesis by activating the IL-8/Notch signaling cascade

  2022cites this paper
• The Interplay between Tumour Microenvironment Components in Malignant Melanoma

  2022cites this paper
• Heme Oxygenase-1 Has a Greater Effect on Melanoma Stem Cell Properties Than the Expression of Melanoma-Initiating Cell Markers

  2022cites this paper
• Heterogeneity in Melanoma

  2022cites this paper
• Regulation of LncRNAs in Melanoma and Their Functional Roles in the Metastatic Process

  2022cites this paper
• Emerging strategies for treating metastasis

  2021cites this paper
• Aldehyde dehydrogenase inhibitors promote DNA damage in ovarian cancer and synergize with ATM/ATR inhibitors

  2021cites this paper
• A Transient Metabolic State in Melanoma Persister Cells Mediated by Chemotherapeutic Treatments

  2021cites this paper
• The Integrative Analysis Identifies Three Cancer Subtypes and Stemness Features in Cutaneous Melanoma

  2021cites this paper
• Effect of melanoma stem cells on melanoma metastasis

  2021influential citation
• Discovery and development of selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors.

  2021cites this paper
• Oral Cancer Stem Cells: Therapeutic Implications and Challenges

  2021cites this paper
• Role of Biomarkers in the Integrated Management of Melanoma

  2021cites this paper
• Characterization of morphological alterations in micropapillary adenocarcinoma of the lung using an established cell line.

  2021cites this paper
• Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted Therapies

  2021cites this paper
• Cell Therapy: The New Approach to Dermatology and Dermatologic Surgery

  2021cites this paper
• CD133 Promotes Resistance to Trametinib in Melanoma Stem Cells by Activating an AKT / BCL-2 Survival Pathway

  2021cites this paper
• Ferroptosis: Cancer Stem Cells Rely on Iron until “to Die for” It

  2021cites this paper
• Deciphering functional tumor states at single‐cell resolution

  2021cites this paper
• Cancer Stem Cells in Patient Survival and Therapies in Cancer

  2020cites this paper
• Exploring metabolic reprogramming in melanoma via acquired resistance to the oxidative phosphorylation inhibitor phenformin

  2020cites this paper
• Cancer Stem Cells: New Horizons in Cancer Therapies

  2020cites this paper
• Development of 2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of aldehyde dehydrogenase 1A (ALDH1A) as potential adjuncts to ovarian cancer chemotherapy.

  2020cites this paper
• Cancer Immunotherapy via Targeting Cancer Stem Cells Using Vaccine Nanodiscs.

  2020cites this paper
• Regulatory Role of Quiescence in the Biological Function of Cancer Stem Cells

  2020cites this paper
• Targeting cancer stem cells in cholangiocarcinoma (Review)

  2020cites this paper
• Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer

  2020cites this paper
• Insights into the Molecular Mechanisms Behind Intralesional Immunotherapies for Advanced Melanoma

  2020cites this paper
• Cancer stem cells, epigenetics, tumor microenvironment and future therapeutics in cutaneous malignant melanoma: a review.

  2020cites this paper
• Identification of very small cancer stem cells expressing hallmarks of pluripotency in B16F10 melanoma cells and their reoccurrence in B16F10-derived clones.

  2020cites this paper
• An evolving paradigm of cancer stem cell hierarchies: therapeutic implications

  2020cites this paper
• Inactivating p53 is essential for nerve growth factor receptor to promote melanoma-initiating cell-stemmed tumorigenesis

  2020cites this paper
• NAD- and NADPH-Contributing Enzymes as Therapeutic Targets in Cancer: An Overview

  2020cites this paper
• Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis–Initiating Cells

  2020cites this paper
• p53 functional states are associated with distinct aldehyde dehydrogenase transcriptomic signatures

  2020cites this paper
• B4GALNT1 induces angiogenesis, anchorage independence growth and motility, and promotes tumorigenesis in melanoma by induction of ganglioside GM2/GD2

  2020cites this paper
• How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance

  2020cites this paper
• Expression of ALDH1A Isozymes in Human Endometrium with and without Endometriosis and in Ovarian Endometrioma

  2020cites this paper
• Evidence for hypoxia increasing the tempo of evolution in glioblastoma

  2020cites this paper
• Evidence for hypoxia increasing the tempo of evolution in glioblastoma

  2020cites this paper
• Targeting cancer stem cell pathways for cancer therapy

  2020cites this paper
• ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells

  2019cites this paper
• Cancer Stem Cell Challenges in Melanoma Characterization and Treatment

  2019cites this paper
• Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation

  2019cites this paper
• Recasting the Cancer Stem Cell Hypothesis: Unification Using a Continuum Model of Microenvironmental Forces

  2019cites this paper
• Phenethyl Isothiocyanate Exposure Promotes Oxidative Stress and Suppresses Sp1 Transcription Factor in Cancer Stem Cells

  2019cites this paper